Patients preparing for body contouring procedures, particularly panniculectomy, may need to reassess their preoperative risk profiles. A new, comprehensive study published in the November issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS), suggests that a history of COVID-19 infection significantly increases the risk of venous thromboembolism (VTE)—a serious and potentially life-threatening complication involving blood clots.
As surgical practices evolve in the post-pandemic era, this research offers a critical lens through which plastic surgeons must view patient safety, suggesting that the physiological legacy of COVID-19 may persist long after the initial infection has cleared.
The Core Findings: A New Variable in Surgical Safety
Panniculectomy is a transformative procedure designed to remove excess skin and adipose tissue from the lower abdomen. While often categorized under body contouring, it serves a functional purpose for many patients who have undergone massive weight loss, alleviating chronic skin rashes, recurring infections, and mobility limitations caused by hanging skin folds.
However, the surgical process—like any major intervention—carries inherent risks. Among the most feared of these is VTE, which encompasses deep vein thrombosis (DVT) and pulmonary embolism (PE). These clots can travel through the bloodstream to the lungs, leading to catastrophic outcomes.
The study, led by Mary Newland, BS, a medical student at Penn State College of Medicine, identifies a clear statistical correlation: patients who have recovered from COVID-19 exhibit a significantly higher incidence of VTE following surgery compared to those who have never contracted the virus.
"Our findings suggest that past COVID may be an additional predisposing risk factor for VTE among patients undergoing panniculectomy," Newland stated. "This may have implications for assessment and prevention of surgical risks of body contouring surgery after major weight loss."
Chronology of the Research: Analyzing a Pandemic-Era Cohort
To reach these conclusions, researchers conducted an extensive analysis of national hospital data, tracking 7,114 patients who underwent functional panniculectomy between 2017 and 2023. This timeframe is essential, as it allows for a direct comparison between surgical outcomes before the pandemic and those during the height of the viral spread.
The Phases of Data Collection:
- Pre-Pandemic Baseline (2017–March 2020): Researchers analyzed 3,015 patients to establish the baseline risk of VTE during standard surgical conditions.
- Post-Pandemic Expansion (March 2020–2023): Researchers monitored 4,099 patients who underwent the procedure after the global onset of COVID-19.
When researchers initially compared the two overarching groups, the results appeared surprisingly consistent. The rate of VTE in the pre-pandemic cohort was 3.2%, while the post-pandemic cohort showed a rate of 3.0%. This initial finding suggested that the overall standard of care—including the routine use of anticoagulant medications (blood thinners) based on the standardized Caprini VTE risk assessment—remained effective.
However, the team realized that "post-pandemic" was too broad a category. To uncover the truth, they narrowed their focus to the 4,099 patients who had surgery after March 2020, segmenting them by their specific COVID-19 history.
Supporting Data: The Impact of Viral History
The granular analysis of the post-pandemic group revealed the true extent of the risk. Among the 4,099 patients, 790 reported a prior history of COVID-19, while 3,309 had no recorded history of the infection.
The discrepancy in surgical outcomes between these two sub-groups was stark:
- Patients with a history of COVID-19: 4.9% experienced postoperative VTE.
- Patients without a history of COVID-19: 2.5% experienced postoperative VTE.
This represents a near-doubling of risk for those who had previously been infected. Critically, the researchers ensured that the two groups were balanced in terms of other comorbidities. Factors known to influence blood clotting—such as pre-existing heart disease, lung conditions, and vascular disorders—were statistically similar across both groups. By controlling for these variables, the researchers strengthened the conclusion that the prior COVID-19 infection was the primary driver of the increased VTE incidence.
The Pathophysiology: Why COVID-19 Changes the Rules
The question remains: why would a virus that primarily attacks the respiratory system increase the risk of blood clots during an abdominal surgery months or even years later?
The authors point toward the lingering effects of the virus on the human vascular system. COVID-19 is well-documented for its ability to induce a state of hypercoagulability—a condition where the blood has an increased tendency to form clots. This "pro-thrombotic" state can persist long after the patient has recovered from acute symptoms, potentially leaving the vascular system more vulnerable to the trauma and immobilization associated with surgery.
When a patient undergoes a panniculectomy, the body is subjected to significant stress, inflammation, and a period of reduced mobility. In a patient whose blood chemistry has been altered by a past COVID-19 infection, these surgical triggers may be enough to tip the balance toward a clot formation, even if the patient appears healthy during their preoperative evaluation.
Official Responses and Clinical Implications
The publication of these findings in Plastic and Reconstructive Surgery® has prompted a broader discussion regarding how plastic surgeons should approach patient consultations.
Refining Risk Assessment
Current surgical protocols rely heavily on the Caprini Risk Score, a validated tool that assigns points to various risk factors (e.g., age, body mass index, type of surgery, history of cancer) to determine the necessary level of blood thinner prophylaxis. The authors of the study argue that "history of COVID-19" may need to be formally integrated into these risk assessment models.
Future Research Directions
The authors emphasize that this study is an essential first step but not the final word. "The study shows the emergence of a new patient population who may be more susceptible to postoperative VTEs," the authors concluded. Future research must now focus on:
- Defining the "Window of Risk": Does the risk of VTE subside after a certain period, or does it remain a permanent factor for those who have had severe COVID-19?
- Tailored Prophylaxis: Should patients with a history of COVID-19 receive more aggressive anticoagulant therapy or longer durations of preventative medication?
- Vaccination Status: Does prior vaccination status mitigate the risk of post-surgical VTE?
Conclusion: A Shift in Surgical Standard of Care
The medical community is constantly learning how to manage the long-term consequences of the COVID-19 pandemic. This study highlights that these consequences are not limited to long-haul respiratory or neurological symptoms but extend into the operating theater.
For patients considering panniculectomy, the takeaway is clear: transparency regarding one’s medical history is more important than ever. Surgeons must engage in detailed conversations with their patients about their COVID-19 history, ensuring that the decision to operate is balanced against the potential, albeit manageable, risk of venous thromboembolism.
As the field of plastic surgery continues to prioritize patient safety, the integration of this new data into clinical practice will be vital in ensuring that patients can achieve their desired functional and aesthetic outcomes without compromising their cardiovascular health.
About the Source
Plastic and Reconstructive Surgery® is the official medical journal of the American Society of Plastic Surgeons (ASPS) and is published by Wolters Kluwer. It remains the leading resource for the plastic surgery community, providing peer-reviewed, evidence-based research that guides the standard of care for millions of patients worldwide.
For further reading on this topic, the full study, "Incidence of Postoperative Venous Thromboembolism following Panniculectomy in Patients with History of COVID-19," can be accessed through the Lippincott/Wolters Kluwer portfolio (doi: 10.1097/PRS.0000000000012202).
About the Author
